Addiction Research

According to the World Health Organization (WHO), addiction is 'a chronic disease of the central nervous system that is characterized by a loss of control over impulsive behavior that leads to compulsive drug seeking and taking, and to relapses even after months of abstinence'. Addiction is a complex neuroadaptive process, where drugs of abuse alter cellular and molecular aspects of neural function. The brain circuits mediating the various behavioral effects of these drugs are rendered more, or less, responsive to those effects.

Addiction Research Products Targets

Products for Addiction Research - Page 15

  1. Cat.No. Product Name Information/Activity
  2. BCC6827 Oleamide Oleamide is an endogenous fatty acid amide which can be synthesized de novo in the mammalian nervous system, and has been detected in human plasma. Oleamide chemical structure
  3. BCC4412 AM251 AM251 is a selective cannabinoid 1 (CB1) receptor antagonist with an IC50 of 8 nM, also acts as a potent GPR55 agonist with an EC50 of 39 nM. AM251 chemical structure
  4. BCC6944 AM 281 Potent, selective CB<sub>1</sub> antagonist/inverse agonist AM 281 chemical structure
  5. BCC1082 CP-945598 HCl Otenabant Hydrochloride is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor. CP-945598 HCl chemical structure
  6. BCC6065 Hemopressin (human, mouse) 1314035-51-2 Hemopressin (human, mouse) chemical structure
  7. BCC5807 Hemopressin (rat) 568588-77-2 Hemopressin (rat) chemical structure
  8. BCC7346 LY 320135 176977-56-3 LY 320135 chemical structure
  9. BCC7852 MJ 15 944154-76-1 MJ 15 chemical structure
  10. BCC7810 NIDA 41020 502486-89-7 NIDA 41020 chemical structure
  11. BCC7746 PF 514273 851728-60-4 PF 514273 chemical structure

Items 141 to 150 of 509 total